Matthew Foehr

COO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LGND

COO

4 calls Latest call 2022-08-08

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$451,057	—	$2,041,319	$1,400,037	—	$115,353	$4,007,766
2021	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$518,933	—	$3,146,844	$1,226,357	$259,467	$130,603	$5,282,204
2020	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$503,750	—	$1,242,269	$1,303,366	$277,063	$158,001	$3,484,449
2019	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$487,500	—	$1,711,163	$1,686,480	$195,000	$164,766	$4,244,909
2018	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$458,931	—	$1,361,147	$1,164,133	$252,412	$87,517	$3,324,140
2017	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$442,094	$30,000	$1,387,985	$1,280,493	$265,256	$52,675	$3,458,503

Earnings-call appearances and filed executive appointments or departures, newest first.